Document is current
Any future updates will be listed below
-
Authors
Kruta, Jan
Carapito, Raphael
Trendelenburg, Marten
Martin, Thierry
Rizzi, Marta
Voll, Reinhard E.
Cavalli, Andrea
Natali, Eriberto
Meier, Patrick
Stawiski, Marc
Mosbacher, Johannes
Mollet, Annette
Santoro, Aurelia
Capri, Miriam
Giampieri, Enrico
Schkommodau, Erik
Miho, Enkelejda
-
Funding
Funding for this research was provided by:
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
Interreg (Interreg V-Projekt Nr. WO 2.2 “PERSONALIS”)
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 10 October 2024
First Online: 13 November 2024
<!--Emphasis Type='Bold' removed-->D<!--Emphasis Type='Bold' removed-->eclarations
:
: Jan Kruta, Raphael Carapito, Marten Trendelenburg, Thierry Martin, Marta Rizzi, Reinhard E. Voll, Andrea Cavalli, Eriberto Natali, Patrick Meier, Marc Stawiski, Johannes Mosbacher, Annette Mollet, Miriam Capri, Enrico Giampieri, Aurelia Santoro and Erik Schkommodau declare that they have no conflict of interest. Enkelejda Miho owns shares in aiNET GmbH.
: This study, involving human participants, complies with the Declaration of Helsinki and has received approvals from the appropriate medical ethical committees. The study has been approved by the CHU Strasbourg Medical Ethical Committee under the approval number CPP- IV- Est- 08/02/2011. Participants gave their informed consent prior to their involvement in the study.
